Human ALKF1174L (analogous to mouse ALKF1178L) is the most frequent somatic mutation in neuroblastoma and is associated with MYCN amplification, conferring a worse prognosis than MYCN amplification alone (35). Here, MYCN is linked to neuroblastoma.